Resolution Therapeutics

CARISMA Therapeutics

This company develops engineered macrophage and monocyte cell therapies to treat patients with solid tumours and liver fibrosis.

Promethera

The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.

Carisma Theraputics

The company develops engineered macrophage and monocyte cell therapies for patients with solid tumours, liver fibrosis and other serious diseases.

Macomics

The company develops macrophage-modulating antibody therapies and precision medicines for patients with cancer and fibrotic diseases.

Agomab

This biopharmaceutical company develops therapies for fibro-inflammatory diseases to treat patients with Crohn's disease, pulmonary fibrosis and liver cirrhosis.

Forth Therapeutics

This biotechnology company develops precision therapeutics for patients with organ fibrosis using a multi-omic discovery platform and human liver disease datasets.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Spica Therapeutics

This biotechnology firm develops monoclonal antibody therapies that target pathogenic macrophage subsets to treat patients with cancer and fibroinflammatory diseases.